Search

Adenocarcinoma is the second largest histological type of cervical cancer, second only to cervical squamous cell carcinoma. At present, despite the clinical treatment strategies of cervical adenocarcinoma and cervical squamous cell carcinoma being similar, the outcome and prognosis of cervical adenocarcinoma are significantly poor. Therefore, it is urgent to find specific biomarker and therapeutic target for cervical adenocarcinoma. In this study, we aim to reveal and verify the potential biomarkers and therapeutic targets of cervical adenocarcinoma. Weighted correlation network analysis (WGCNA) reveals the differentially-expressed genes significantly related to the histological characteristics of the two cervical cancer subtypes. We select the genes with the top 20 significance for further investigation. Through microarray and immunohistochemical (IHC) analyses of a variety of tumor tissues, we find that among these 20 genes, AHNAK2 is highly expressed not only in cervical adenocarcinoma, but also in multiple of adenocarcinoma tissues, including esophagus, breast and colon, while not in normal gland tissues. In vitro, AHNAK2 knockdown significantly inhibits cell proliferation and migration of adenocarcinoma cell lines. In vivo, AHNAK2 knockdown significantly inhibits tumor progression and metastasis of various adenocarcinomas. RNA-sequencing and bioinformatics analyses suggest that the inhibitory effect of AHNAK2 knockdown on tumor progression is achieved by regulating DNA replication and upregulating Bim expression. Together, we demonstrate that AHNAK2 is a biomarker and a potential therapeutic target for adenocarcinomas.

The ITER Organization (10) and the Institute of Plasma Physics at the Chinese Academy of Sciences (ASIPP) are jointly developing the 68 kA current leads using High Temperature Superconductors for the superconducting Toroidal Field (TF) magnet system of the International Thermonuclear Experimental Reactor, ITER. The proposed design consists of a conventional helium cooled heat exchanger operating between 65 K and 320 K and an HTS module covering the low temperature end using Bi-2223 tapes. The first HTS current lead prototypes will be tested in the EAST tokamak facility at ASIPP. This paper discusses the design of the first, 68 kA, TF HTS lead, which is the main emphasis of this first stage of the ITER current lead development program. [ABSTRACT FROM AUTHOR]

Vibration exercise (VE) has shown promising results for improving muscle strength and power performance when superimposed on high-level muscle contraction. However, low-level contraction may be more preferable in many rehabilitation programs due to the weakness of the patients. Unfortunately, the effects and underlying physiological mechanisms of VE superimposed on low-level contraction are unclear. This study aims to investigate the fatiguing effects and motor unit (MU) firing patterns during VE with low-level muscle contraction. Twenty-one healthy participants performed 60-s isometric contraction of the upper limb under a baseline force at 30% maximum voluntary contraction and superimposed vibration with an amplitude of 50% baseline and different frequencies at 0 Hz (control), 15, 25, 35, and 45 Hz. High-density surface electromyography (EMG) was recorded on the biceps brachii. The decay in muscle fiber conduction velocity, calculated in 3-s sliding windows, was employed as an indicator of myoelectric fatigue. MU firing patterns were obtained by decomposing the high-density EMG into MU spike trains. VE, particularly at 25 Hz, produces increased myoelectric fatigue as compared to the control condition. Besides, synchronized MU discharges are observed at the vibration frequency for 15- and 25-Hz VE and the sub-harmonics for 35- and 45-Hz VE. Furthermore, VE-induced increase in MU synchronization (as compared to control) seems to decrease with myoelectric fatigue. Significance: Our findings suggest that VE may be a suitable modality for rehabilitation programs, providing useful insights for subscribing appropriate VE training protocols.